Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Klaria has secured subscription and underwriting commitments equivalent to approximately 75.3 percent of the rights offering, as well as bridge financing of approximately SEK 30.7 million

$KLARPress releaseOct 8, 2026, 4:14 AM ETRead the release

Klaria Pharma announced its rights offering of up to 61,494,038 units at SEK 2.40 per unit (~147.6 MSEK before costs) is covered by subscription and underwriting commitments totaling approximately SEK 111.1 million, or 75.3% of the offering. The company also secured bridge financing of approximately SEK 30.7 million from existing shareholders and external investors to settle short-term obligations ahead of the raise. Guarantee commitments of SEK 74.1 million are provided by Vator Securities, with fees of 12-16% of guaranteed amounts.

Key figures

Deal Value Usd
0
Offering Price
SEK 2.40 per unit (SEK 0.60 per share)
Shares Offered
61494038
Unit structure
4 new shares + 1 TO1 warrant per unit
Bridge financing
approximately SEK 30.7 million
Max setoff amount
approximately SEK 48.7 million
Total commitments
approximately SEK 111.1 million (75.3% coverage)
Floor guarantee fee
12% cash or 14% in units
Topup guarantee fee
14% cash or 16% in units
Rights offering size
approximately 147.6 MSEK before expenses
Guarantee commitments
approximately SEK 74.1 million (bottom-up SEK 34.0M, top-up SEK 40.1M)
Subscription commitments
approximately SEK 37.1 million (25.1%)

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    KLAR: Klaria has secured subscription and underwriting commitments equivalent to approximately 75.3 percent of the rights offering, as well as bridge financing of approximately SEK 30.7 million — AI Analysis | Signal8